Scarica l'app Stockscreener
89.19
0.36%
-0.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$89.51
Aprire:
$89.625
Volume 24 ore:
12.97M
Relative Volume:
1.04
Capitalizzazione di mercato:
$222.78B
Reddito:
$63.43B
Utile/perdita netta:
$16.42B
Rapporto P/E:
13.75
EPS:
6.4861
Flusso di cassa netto:
$14.72B
1 W Prestazione:
+13.53%
1M Prestazione:
+5.95%
6M Prestazione:
+3.24%
1 anno Prestazione:
-19.05%
Intervallo 1D:
$88.10
$90.70
Intervallo di 1 settimana:
$78.03
$91.00
Portata 52W:
$73.31
$111.58
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
89.19 | 223.58B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
839.87 | 734.96B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
188.64 | 447.90B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
233.91 | 417.90B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
132.39 | 253.54B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Bernstein Maintains a Hold Rating on Merck & Co (MRK) - MSN
Merck: A Race Against The Keytruda Clock (NYSE:MRK) - Seeking Alpha
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting - GlobeNewswire Inc.
What Does Wall Street Think About Merck & Co. (MRK)? - MSN
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? - Yahoo Finance
Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR - Yahoo Finance
Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial - MSN
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 - PharmiWeb.com
ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail
European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty - Reuters
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck (MRK) Shares Skyrocket, What You Need To Know - Yahoo Finance
Bernstein Maintains a Hold Rating on Merck & Co. (MRK) - Yahoo Finance
Merck’s Keytruda Approval: What’s Next? - StocksToTrade
How Merck & Co. (MRK) Turns Robust Free Cash Flow Into Shareholder Value - Yahoo Finance
Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio - Yahoo Finance
Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension PatientsMerck & Co (NYSE:MRK) - Benzinga
Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - MSN
Bourgeon Capital Management LLC Acquires 10,748 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Union Bancaire Privee UBP SA - MarketBeat
Emerald Advisors LLC Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Mainsail Financial Group LLC Invests $309,000 in Merck & Co., Inc. $MRK - MarketBeat
Park Place Capital Corp Purchases 10,386 Shares of Merck & Co., Inc. $MRK - MarketBeat
Greenleaf Trust Sells 19,620 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by XML Financial LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Capital Investment Advisors LLC - MarketBeat
Sterling Investment Advisors Ltd. Sells 3,254 Shares of Merck & Co., Inc. $MRK - MarketBeat
Janney Montgomery Scott LLC Sells 42,991 Shares of Merck & Co., Inc. $MRK - MarketBeat
GC Wealth Management RIA LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Avior Wealth Management LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development - Yahoo Finance
With 80% Ownership, Merck & Co., Inc. (NYSE:MRK) Boasts of Strong Institutional Backing - 富途牛牛
Merck (MRK) Announces Positive Recommendation from EU Medicines Agency - MSN
Smith Chas P & Associates PA Cpas Has $28.12 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by FARMERS & MERCHANTS TRUST Co OF LONG BEACH - MarketBeat
Cairn Investment Group Inc. Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by V Square Quantitative Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Investment Research & Advisory Group Inc. - MarketBeat
Moody Lynn & Lieberson LLC Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 29% Upside Potential and Robust Dividend Yield - DirectorsTalk Interviews
Sonora Investment Management Group LLC Sells 169,105 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug - MSN
Addenda Capital Inc. Has $6.12 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
San Luis Wealth Advisors LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - sharewise.com
Merck & Co., Inc. $MRK Stake Boosted by Financial Partners Group LLC - MarketBeat
Coastline Trust Co Has $1.72 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Tritonpoint Wealth LLC Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Fort Washington Investment Advisors Inc. OH Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Stockman Wealth Management Inc. - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):